Hybrid Conferencee

International Conference on Biotechnology, Genomics, and Legal Implications in Health Care (ICBGLIHC - 26)

23rd - 24th December 2026 | Dallas, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Dallas. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Dallas event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Dallas conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Dallas, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Dallas."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 9
SDG 9 Industry, Innovation and Infrastructure
SDG 10
SDG 10 Reduced Inequalities
Track 01

Regulatory Frameworks in Biotechnology

This track explores the evolving regulatory landscapes governing biotechnology innovations. It aims to analyze the implications of these frameworks on health care delivery and patient safety.

Track 02

Legal Challenges in Genetic Testing

This session focuses on the legal implications surrounding genetic testing, including issues of consent and liability. Participants will discuss how current laws address the complexities of genetic information and its use in health care.

Track 03

Bioethics and Patient Rights

This track examines the intersection of bioethics and legal rights in health care, particularly in the context of biotechnology. It aims to foster discussions on ethical standards that protect patient autonomy and informed consent.

Track 04

Intellectual Property in Genomic Medicine

This session delves into the challenges and opportunities presented by intellectual property laws in the field of genomic medicine. Participants will explore how these laws impact innovation and access to biotechnological advancements.

Track 05

Data Privacy and Health Care Law

This track addresses the critical issues of data privacy and security in health care, especially concerning genomic data. It will explore legal frameworks that govern data protection and the implications for patient confidentiality.

Track 06

Clinical Trials and Regulatory Compliance

This session focuses on the legal requirements and ethical considerations involved in conducting clinical trials. Participants will discuss best practices for ensuring regulatory compliance and protecting participant rights.

Track 07

Gene Therapy: Legal and Ethical Perspectives

This track examines the legal and ethical challenges associated with gene therapy, including issues of liability and patient consent. It aims to facilitate discussions on the regulatory landscape and ethical standards governing this emerging technology.

Track 08

Emerging Technologies and Health Policy

This session explores the implications of emerging biotechnological innovations on health policy and regulation. Participants will discuss how policymakers can adapt legal frameworks to accommodate rapid advancements in the field.

Track 09

Biotech Governance and Ethical Standards

This track investigates the governance structures that oversee biotechnological research and innovation. It aims to highlight the importance of ethical standards in ensuring responsible practices within the biotech industry.

Track 10

Research Ethics in Genomics

This session focuses on the ethical considerations in genomic research, including issues of consent, equity, and access. Participants will discuss frameworks for ensuring ethical integrity in genomic studies.

Track 11

Innovation Law in Health Care

This track examines the role of innovation law in shaping the future of health care, particularly in biotechnology and genomics. It aims to explore how legal frameworks can foster innovation while ensuring public safety and ethical standards.